Edwards Lifesciences

Edwards Lifesciences

Yahoo Finance • yesterday

Edwards Lifesciences' Progress Data Unlikely to Expand TAVR Market, RBC Says

Edwards Lifesciences' (EW) Progress trial is unlikely to meaningfully expand the market for transcat Keep reading this article with Yahoo Finance Plus Silver Upgrade to Silver Silver Premium news Full access to Financial Times and MT N... Full story

Yahoo Finance • 13 days ago

Does Valve Repair Approval Change The Bull Case For Edwards Lifesciences (EW)?

Edwards Lifesciences reported past FDA approvals for its PASCAL Precision system for tricuspid valve repair and PASCAL Ace with Capture Clarity for degenerative mitral TEER, giving the business a broader U.S. transcatheter repair toolkit f... Full story

Yahoo Finance • 14 days ago

Is This the Right Time to Hold EW Stock in Your Portfolio?

Edwards Lifesciences EW sees Transcatheter Mitral and Tricuspid Therapies ("TMTT") momentum, fueled by PASCAL, EVOQUE and SAPIEN M3, supported by clinical evidence and broader market access. The company's Transcatheter Aortic Valve Replace... Full story

Yahoo Finance • 29 days ago

Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026

IRVINE, Calif., October 07, 2026--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended Sept. 30, 2026 after the market closes on Wednesday, Nov. 4, and will host a conference call a... Full story

Yahoo Finance • last month

Edwards gains FDA approval of AUTUS pulmonary valve for pediatric patients

[Edwards Lifesciences facility in Draper, Utah, USA.] JHVEPhoto * The US FDA approved Edwards Lifesciences (EW [https://seekingalpha.com/symbol/EW]) AUTUS surgical pulmonary valve for pediatric patients with congenital heart disease.... Full story

Yahoo Finance • last month

Stock index futures rise as investors focus on Trump-Xi summit

[Wall Street New York stock exchange stock market] alexsl Stock index futures were higher on Monday as attention turned to the upcoming U.S.-China summit, even as tensions in the Middle East appeared to worsen. Dow futures (INDU [https:... Full story

Yahoo Finance • 2 months ago

How Investors May Respond To Edwards Lifesciences (EW) Expanded TAVR Access And Transcatheter Valve Ambitions

Edwards Lifesciences recently outlined its structural heart growth plan, emphasizing transcatheter valve platforms such as TAVR and TMTT, alongside the impact of updated Medicare coverage that could enable 100–200 additional U.S. centers t... Full story

Yahoo Finance • 2 months ago

Interventional Cardiology Devices Market by Type, End User - Global Forecast to 2031

Company Logo The global interventional cardiology devices market is forecast to grow from USD 31.12 billion in 2026 to USD 42.39 billion by 2031, at a 6.4% CAGR. Growth is driven by rising cardiovascular disease, aging populations, demand... Full story

Yahoo Finance • 2 months ago

Edwards Lifesciences praises CMS NCD on transcatheter aortic valve replacement

asikkk/iStock via Getty Images * Edwards Lifesciences (EW [https://seekingalpha.com/symbol/EW]) said that an updated CMS national coverage determination will ease patient access to transcatheter aortic valve replacement. * The NCD sta... Full story

Yahoo Finance • 2 months ago

Edwards Lifesciences to Present at the Deutsche Bank Healthcare Summit

IRVINE, Calif., September 02, 2026--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) will participate in the Deutsche Bank Healthcare Summit on Wednesday, Sept. 16, 2026. Bernard Zovighian, chief executive officer, is schedule... Full story

Yahoo Finance • 2 months ago

Why Is ISRG Investing More Aggressively in R&D Despite Macro Headwinds?

Intuitive Surgical ISRG is deliberately prioritizing research and development to fuel long-term growth, offsetting near-term challenges from macroeconomic uncertainty, healthcare policy changes and international competitive pressures. In... Full story

Yahoo Finance • 2 months ago

Edwards Lifesciences (EW): The Medical Device Leader Behind the TAVR Boom

Aristotle Capital Management, LLC, an investment management company, released its "Value Equity Fund" Q2 2026 investor letter. A copy of the letter can be downloaded here. The Fund delivered a 4.32% total return in Q2 2026, underperforming... Full story

Yahoo Finance • 2 months ago

MDT's Q1 Earnings on Deck: How Should You Play the Stock Now?

Medtronic plc MDT is slated to report its first-quarter fiscal 2027 results on Sept. 1, before the opening bell. The Zacks Consensus Estimate for the company's first-quarter earnings per share (EPS) suggests 10.3% year-over-year growth to... Full story

Yahoo Finance • 2 months ago

Is Edwards Lifesciences (EW) A Bargain Following Its Asia Pacific Patient Experience Event?

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Edwards Lifesciences (EW) recently held its annual Asia Pacific Patient Experience event, spotli... Full story

Yahoo Finance • 3 months ago

Putting Patients at the Heart of Innovation: Voices Across Asia Pacific Help Shape the Future of Structural Heart Care

Patients from Australia, India, Indonesia, South Korea and Singapore gathered at Edwards Lifesciences' annual APAC Patient Experience event to share their stories and help advance more patient-centered care. SINGAPORE, Aug. 19, 2026 /PRNe... Full story

Yahoo Finance • 3 months ago

Edwards Lifesciences (EW) Has a Growth Runway Competitors May Struggle to Match

Baron Capital, an investment management company, released its Q2 2026 investor letter for the "Baron Health Care Fund". A copy of the letter is available to download here. The Fund gained 11.99% during the quarter, compared with the 10.48%... Full story

Yahoo Finance • 3 months ago

Intuit downgrade, Intuitive Surgical upgraded: Wall Street's top analyst calls

Intuit downgrade, Intuitive Surgical upgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as... Full story

Yahoo Finance • 3 months ago

AtriCure, Inc. (ATRC) Beat Earnings Estimates. Here’s What Could Drive ATRC Stock Next

AtriCure, Inc. (NASDAQ:ATRC) has been delivering revenue growth and improved profitability, but the bigger question for investors is whether the latest results had any underlying catalysts strong enough to support the long-term growth pote... Full story

Yahoo Finance • 3 months ago

Edwards Lifesciences (EW) Stock Looks Fair On Cash Flow While Earnings Trade At A Premium

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Edwards Lifesciences stock sits at an interesting spot for valuation focused investors, with the D... Full story

Yahoo Finance • 3 months ago

Stock index futures edge higher as investors seek rebound after Thursday selloff

[Wall Street New York stock exchange stock market] alexsl Stock index futures were higher on Friday as the stock market hoped to recover from Thursday's selloff. Dow futures (INDU [https://seekingalpha.com/symbol/INDU]) +0.33%, S&P 500... Full story